The Insider For Genpact Limited (G) Sold 1,700 Shares.

The stock of Genpact Limited (NYSE:G) increased by $0.48 on Friday to finish at $36.63, up 1.33 percent. The last five days have seen an average of 929,560 shares of common stock traded. 10 times new highs were reached in the current year, with a fall of -$9.69. The average number of shares traded over the last 20 days was 1,410,470, while the average volume over the last 50 days totaled 1,294,386.

G stock dropped -1.24% since last month. On 08/08/23, the company’s shares reached a one-month low of $35.31. The stock touched a high of $48.85 on 02/23/23, after rallying from a low of $35.31 in 52 weeks. The price of G stock has declined by -20.92% or -$9.69 this year, reaching a new high 10 times. Still, the stock price is down -25.02% from the 52-week high.

Insider Transactions

G stock investors should be aware that Genpact Limited (G) stock had its last reported insider trading activity 12 days ago on Aug 16. On Aug 16, President and CEO Tyagarajan N. V. sold 1,700 shares at $35.89 each. This transaction resulted in the insider making $61,014. On Jun 02, Mehta Piyush sold 29,491 shares at a price of US$37.18. After the transaction, the insider now owns 106,212 shares. Senior Vice President and CHRO Mehta Piyush had earlier sold 41,062 shares on Jun 01 for $37.02 a share. The transaction was completed for $1,519,922.

Valuation Metrics

Genpact Limited (G) has a trailing price-to-earnings (P/E) ratio of 16.80. Beta for the stock is 1.18. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.49, the price-to-book (PB) ratio of 3.47, and the price-to-cash flow ratio of 12.10.

Company paid $0.1375 per share in dividends, remained unchanged from $0.1375 last year.

Financial Health

For the three months ended June 29, Genpact Limited’s quick ratio was 1.90, while its current ratio was 1.90, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.64, and the total debt to equity ratio is 0.72. As far as profitability goes, gross margin for the trailing twelve months is 34.90% percent. Genpact Limited’s EBITDA margin for the year ended June 29 was 15.53%, whereas its operating margin stood at 12.70% for the same period. Based on annual data, it had gross profit of $1.54 billion and revenue of $4.37 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. G’s return on assets (ROA) during the last 12 months has been 9.00%. There was a 11.90% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 22.00%.

Earnings Surprise

According to Genpact Limited’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.11 billion, while revenues rose by 1.44% to $1.09 billion. It was predicted that Genpact Limited’s quarterly earnings would be $0.72, but it ended up being $0.69, beating the consensus by 4.30%. EBITDA was $184.16 million for the quarter. At the end of Genpact Limited’s most recent quarter ended June 29, its liabilities totaled 2.55 billion, while its total debt was $1.6 billion. Equity owned by shareholders amounts to $181.32 million.

Technical Picture

Here’s a quick look at Genpact Limited’s (G) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 51.45%, suggesting the stock is Neutral, with a 21.76% historical volatility rate.

The stochastic %K and %D were 38.44% and 36.39% respectively, while the average true range (ATR) was 0.81. Based on the 14-day stochastic reading of 41.25%, the RSI (14) reading is 48.85%. On the 9-day MACD Oscillator, the stock is at 0.31, and the 14-day reading is at 0.21.

Analyst Ratings

Genpact Limited (NYSE: G) was downgraded by JP Morgan to a an Underweight rating in its latest research report. The stock was previously rated as a a Neutral.

Most Popular

Related Posts